temoporfin has been researched along with Disease Models, Animal in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Anabella, G; Ángel, PM; Carlos, P; Eugenia, EM; Horacio, P; Mario, G; Solange, B | 1 |
| Cheng, CC; Chiang, PF; Chiang, WL; Lin, HC; Luo, TY; Peng, CL; Shieh, MJ; Shih, YH | 1 |
| Foster, TH; Mitra, S; Wang, KK | 1 |
| Bhatti, G; Bielawski, J; Korbelik, M; Merchant, S; Ogretmen, B; Pierce, JS; Separovic, D; Tarca, AL | 1 |
| Bovis, MJ; Bown, SG; Loizidou, M; Macrobert, AJ; Scheglmann, D; Woodhams, JH | 1 |
| Altermatt, HJ; Krueger, T; Magnusson, L; Mettler, D; Ris, HB; Scholl, B | 1 |
| Brown, SB; Jones, HJ; Vernon, DI | 1 |
| Altermatt, HJ; Krueger, T; Opitz, I; Pan, Y; Ris, HB; Wagnières, G | 1 |
| Boettcher, J; Bräuer, R; Frey, O; Gajda, M; Hansch, A; Kaiser, WA; Susanna, G | 1 |
| Alian, W; Andersson-Engels, S; Svanberg, K; Svanberg, S | 1 |
| Abramson, AL; Batti, J; Lee, CJ; Lofgren, LA; Nouri, M; Ronn, AM; Shikowitz, MJ; Steinberg, BM | 1 |
| Batti, J; Lee, CJ; Lofgren, LA; Nouri, M; Ronn, AM; Siegel, ME; Steinberg, BM; Yoo, D | 1 |
| Helmerhorst, TJ; Kenemans, P; Oppelaar, H; Ruevekamp, MC; Stewart, FA; Veenhuizen, RB | 1 |
| Jakober, R; Kostron, H; Obwegeser, A | 1 |
| Berns, MW; Fehr, MK; Hornung, R; Krasieva, TB; Monti-Frayne, J; Tadir, Y; Tromberg, BJ | 1 |
| Bossu, E; Guillemin, F; Notter, D; Padilla-Ybarra, JJ; Vigneron, C | 1 |
| Bezdetnaya, LN; Brault, D; Guillemin, F; Melnikova, VO; Potapenko, AY | 1 |
| Baas, P; Oppelaar, H; Ruevekamp, M; Schouwink, H; Stewart, FA; van Veen, R | 1 |
| Korbelik, M; Sun, J | 1 |
| Flechtenmacher, C; Kübler, AC; Reuther, T; Sinn, H; Zillmann, U | 1 |
21 other study(ies) available for temoporfin and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Photodynamic therapy in fibrosarcoma BALB/c animal model: Observation of the rebound effect.
Topics: Animals; Disease Models, Animal; Fibrosarcoma; Mesoporphyrins; Mice; Mice, Inbred BALB C; Photochemotherapy; Photosensitizing Agents | 2018 |
Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Colorectal Neoplasms; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Kaplan-Meier Estimate; Mesoporphyrins; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents; Receptors, Vascular Endothelial Growth Factor; Tumor Burden; Vascular Endothelial Growth Factor A | 2018 |
Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals.
Topics: Algorithms; Animals; Computer Simulation; Disease Models, Animal; Mesoporphyrins; Mice; Models, Biological; Neoplasms; Photochemotherapy; Photosensitizing Agents; Radiation Dosage; Singlet Oxygen; Time Factors | 2008 |
Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response.
Topics: Animals; Biomarkers; Carcinoma, Squamous Cell; Ceramides; Disease Models, Animal; Female; Head and Neck Neoplasms; Mesoporphyrins; Mice; Mice, Inbred C3H; Photochemotherapy; Photosensitizing Agents; Pyridinium Compounds; Spectrometry, Mass, Electrospray Ionization; Sphingolipids; Treatment Outcome | 2011 |
Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Female; Fibrosarcoma; Light; Liposomes; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Rats; Rats, Wistar; Tissue Distribution | 2012 |
Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.
Topics: Animals; Computer Systems; Disease Models, Animal; Female; Mesoporphyrins; Mesothelioma; Mice; Mice, Nude; Photochemotherapy; Photosensitizing Agents; Pleural Neoplasms; Pneumonectomy; Polyethylene Glycols; Radiometry | 2003 |
Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics.
Topics: Animals; Disease Models, Animal; Drug Administration Schedule; Fibrosarcoma; Half-Life; Kinetics; Male; Mesoporphyrins; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Rats | 2003 |
Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Mesoporphyrins; Mesothelioma; Mice; Necrosis; Photochemotherapy; Photosensitizing Agents; Pleural Neoplasms; Porphyrins; Rats; Rats, Inbred F344; Survival Rate; Verteporfin | 2006 |
Photodynamic treatment as a novel approach in the therapy of arthritic joints.
Topics: Animals; Arthritis, Rheumatoid; Disease Models, Animal; Male; Mesoporphyrins; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Photochemotherapy; Photosensitizing Agents | 2008 |
Laser-induced fluorescence studies of meso-tetra(hydroxyphenyl)chlorin in malignant and normal tissues in rats.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Disease Models, Animal; Fluorescence; Lasers; Male; Mesoporphyrins; Muscle, Skeletal; Neoplasm Transplantation; Photochemotherapy; Radiation-Sensitizing Agents; Rats; Rats, Inbred WF; Spectrometry, Fluorescence; Tissue Distribution | 1994 |
Photodynamic therapy using m-tetra(hydroxyphenyl) chlorin. An animal model.
Topics: Animals; Antineoplastic Agents; Clinical Protocols; Cottontail rabbit papillomavirus; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Monitoring; Laryngeal Neoplasms; Mesoporphyrins; Papillomavirus Infections; Photochemotherapy; Rabbits; Skin Neoplasms; Time Factors; Tumor Virus Infections | 1994 |
Comparative biodistribution of meta-Tetra(Hydroxyphenyl) chlorin in multiple species: clinical implications for photodynamic therapy.
Topics: Animals; Disease Models, Animal; Dogs; Humans; Mesoporphyrins; Photosensitizing Agents; Rabbits; Rats; Rats, Nude; Species Specificity; Tissue Distribution | 1997 |
Foscan-mediated photodynamic therapy for a peritoneal-cancer model: drug distribution and efficacy studies.
Topics: Adipose Tissue; Animals; Disease Models, Animal; Female; Injections, Intraperitoneal; Injections, Intravenous; Mesoporphyrins; Neoplasm Transplantation; Peritoneal Neoplasms; Photochemotherapy; Photosensitizing Agents; Rats; Tissue Distribution | 1997 |
Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model.
Topics: Aminolevulinic Acid; Animals; Brain; Brain Neoplasms; Carbon Radioisotopes; Disease Models, Animal; Female; Glioma; Mesoporphyrins; Photosensitizing Agents; Radionuclide Imaging; Rats | 1998 |
Highly selective targeting of ovarian cancer with the photosensitizer PEG-m-THPC in a rat model.
Topics: Animals; Disease Models, Animal; Female; Mesoporphyrins; Ovarian Neoplasms; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Rats; Rats, Inbred F344 | 1999 |
Determination of the maximal carcinoma/normal skin ratio after HpD or m-THPC administration in Hairless mice (SKH-1) by fluorescence spectroscopy.
Topics: Animals; Carcinoma; Disease Models, Animal; Female; Hematoporphyrins; Injections, Intraperitoneal; Mesoporphyrins; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Predictive Value of Tests; Skin; Skin Neoplasms; Spectrometry, Fluorescence; Tissue Distribution | 2000 |
Enhancement of meta-tetrahydroxyphenylchlorin-sensitized photodynamic treatment on human tumor xenografts using a water-soluble vitamin E analogue, Trolox.
Topics: Animals; Antineoplastic Agents; Antioxidants; Chromans; Disease Models, Animal; Drug Interactions; Female; HT29 Cells; Humans; Mesoporphyrins; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Oxygen; Photochemotherapy; Photosensitizing Agents; Transplantation, Heterologous | 2000 |
Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.
Topics: Animals; Carbon Dioxide; Combined Modality Therapy; Disease Models, Animal; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Humans; Mesoporphyrins; Mesothelioma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Niacinamide; Oxygen; Photochemotherapy; Photosensitizing Agents | 2001 |
Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Disease Models, Animal; Female; HT29 Cells; Humans; Immunotherapy, Adoptive; Killer Cells, Natural; Mesoporphyrins; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Photochemotherapy; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Dermatitis, Phototoxic; Dihematoporphyrin Ether; Disease Models, Animal; Excipients; Female; Head and Neck Neoplasms; Humans; Mesoporphyrins; Mice; Middle Aged; Photochemotherapy; Polyethylene Glycols; Radiation-Sensitizing Agents; Random Allocation; Transplantation, Heterologous; Treatment Outcome; Tumor Cells, Cultured | 2001 |